How has the use of evidence-based therapy and survival in heart failure changed in Sweden from 2003 to 2012?
Survival in heart failure has not improved over the last decade in Sweden, suggesting a leveling off of historical improvements and a need for better implementation of evidence-based therapies.
In this large nationwide registry, over the last decade the use of evidence-based drug therapy was high and remained stable over time, but, despite an increased use of device therapy, the absolute use was poor. This was associated with an absence of improvement in survival. The improvements in therapy and prognosis over the last generation may be levelling off, and efforts should be directed at improving implementation of evidence-based therapy.
Thorvaldsen et al. (2016) studied this question.